Table 2. Correlations of plasma resistin and normalized resistin mRNA with other parameters in the patients group.
| Parameter | Resistin protein | Normalised resistin mRNA | ||
|---|---|---|---|---|
|
ρ |
P |
ρ |
P |
|
| Age | 0.214 | 0.062 | 0.026 | 0.827 |
| BMI | -0.202 | 0.082 | -0.098 | 0.410 |
| Creatinine | 0.353 | 0.002 | 0.166 | 0.156 |
| Glucose | -0.050 | 0.678 | -0.086 | 0.482 |
| TC | -0.373 | 0.001 | -0.111 | 0.356 |
| HDL-C | -0.404 | <0.001 | -0.257 | 0.032 |
| LDL-C | -0.231 | 0.051 | -0.093 | 0.442 |
| Tg | 0.048 | 0.684 | -0.032 | 0.791 |
| hsCRP | 0.124 | 0.288* | 0.164 | 0.165 |
| Insulin | 0.014 | 0.911 | 0.052 | 0.693 |
| HOMA-IR | -0.118 | 0.359 | -0.086 | 0.512 |
| IL-6 | 0.206 | 0.197 | 0.297 | 0.048 |
| Normalised IL-6 mRNA | -0.056 | 0.636 | 0.026 | 0.823 |
| Resistin | / | / | 0.305 | 0.008 |
| Normalised resistin mRNA | 0.305 | 0.008 | / | / |
BMI - body mass index; TC - total cholesterol; LDL-C - low density lipoprotein cholesterol; HDL-C - high density lipoprotein cholesterol; Tg - triglycerides; hsCRP - high sensitivity C-reactive protein; HOMA-IR - homeostasis model assessment of insulin resistance; IL-6 - interleukin 6. *Significant when patients on statin therapy were excluded: P = 0.047, ρ = 0.295